(3R)-3-[(5-amino-1,3,4-thiadiazol-2-yl)sulfanyl]-7-(2,2-difluoroethoxy)-2-hydroxy-3,4-dihydro-1,2-benzoxaborinine-8-carboxylic acid

ID: ALA4637580

PubChem CID: 140786623

Max Phase: Preclinical

Molecular Formula: C13H12BF2N3O5S2

Molecular Weight: 403.20

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Nc1nnc(S[C@H]2Cc3ccc(OCC(F)F)c(C(=O)O)c3OB2O)s1

Standard InChI:  InChI=1S/C13H12BF2N3O5S2/c15-8(16)4-23-6-2-1-5-3-7(25-13-19-18-12(17)26-13)14(22)24-10(5)9(6)11(20)21/h1-2,7-8,22H,3-4H2,(H2,17,18)(H,20,21)/t7-/m0/s1

Standard InChI Key:  ZGSIYEBJAVKZBU-ZETCQYMHSA-N

Molfile:  

 
     RDKit          2D

 26 28  0  0  0  0  0  0  0  0999 V2000
    5.9244   -3.0151    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6408   -2.6017    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6380   -1.7713    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9226   -1.3621    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2096   -2.6022    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2138   -1.7748    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5033   -1.3599    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7841   -1.7676    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7800   -2.5950    0.0000 B   0  0  0  0  0  0  0  0  0  0  0  0
    4.4950   -3.0146    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.9242   -3.8400    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2096   -4.2523    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.6386   -4.2526    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.0630   -3.0032    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.0723   -1.3506    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    2.3553   -1.7585    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6069   -1.4148    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    1.0510   -2.0244    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4589   -2.7414    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.2668   -2.5749    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.3559   -3.0131    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.0696   -2.5995    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7848   -3.0108    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4985   -2.5972    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    8.7861   -3.8358    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    0.2311   -1.9329    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  5  1  1  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  6  1  0
  5  6  2  0
  5 10  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  1 11  1  0
 11 12  1  0
 11 13  2  0
  9 14  1  0
  8 15  1  1
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 16  2  0
  2 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 23 25  1  0
 18 26  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4637580

    ---

Associated Targets(non-human)

KPC-2 Beta-lactamase (208 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 403.20Molecular Weight (Monoisotopic): 403.0279AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Hecker SJ, Reddy KR, Lomovskaya O, Griffith DC, Rubio-Aparicio D, Nelson K, Tsivkovski R, Sun D, Sabet M, Tarazi Z, Parkinson J, Totrov M, Boyer SH, Glinka TW, Pemberton OA, Chen Y, Dudley MN..  (2020)  Discovery of Cyclic Boronic Acid QPX7728, an Ultrabroad-Spectrum Inhibitor of Serine and Metallo-β-lactamases.,  63  (14): [PMID:32150407] [10.1021/acs.jmedchem.9b01976]

Source